{"id":5837,"date":"2024-10-15T04:10:10","date_gmt":"2024-10-15T09:10:10","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5837"},"modified":"2025-06-27T08:34:47","modified_gmt":"2025-06-27T13:34:47","slug":"nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30012024\u5e74\u30a2\u30e1\u30ea\u30ab\u773c\u79d1\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a\u3067\u306e\u767a\u8868\u3092\u767a\u8868"},"content":{"rendered":"
\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n

\u30c0\u30e9\u30b9<\/span><\/span>,\u00a02024\u5e7410\u670815\u65e5<\/span><\/span>\u00a0\u2014 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e<\/a>\u7db2\u819c\u5909\u6027\u75be\u60a3\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3057\u3066\u3044\u308bBLA\u7533\u8acb\u6bb5\u968e\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u306f\u3001\u672c\u65e5\u3001Nanoscope\u304c\u00a0AAO 2024 \u5e74\u6b21\u7dcf\u4f1a<\/a>\u00a0\u8d77\u3053\u3063\u3066\u3044\u308b\u00a02024\u5e7410\u670818\u65e5\u301c21\u65e5<\/span>\u00a0\u3067\u00a0\u30a4\u30ea\u30ce\u30a4\u5dde\u30b7\u30ab\u30b4<\/span>\u3001\u304a\u3088\u3073\u95a2\u9023\u3059\u308b\u00a0\u30a2\u30a4\u30bb\u30ec\u30ec\u30fc\u30bf\u30fc @ AAO 2024<\/a>\u00a0\u305d\u3057\u3066\u00a0\u7db2\u819c\u3092\u9769\u65b0\u3059\u308b<\/a>\u00a0\u4f1a\u8b70\u306f\u4e21\u65b9\u3068\u3082\u00a010\u670817\u65e5<\/span>\u756a\u76ee<\/sup>\u30012024\u5e74\u3002\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u8a73\u7d30\u306f\u6b21\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n

\u30bf\u30a4\u30c8\u30eb\uff1a\u00a0<\/b>RP\u306b\u3088\u308b\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u60a3\u8005\u306b\u5bfe\u3059\u308b\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306eMCO-010\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u7642\u6cd5\u306e\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027\uff1a\u30d5\u30a7\u30fc\u30ba2\u8a66\u9a13\u306e2\u5e74\u9593\u306eTOPLINE\u7d50\u679c\u00a02b<\/span>\/3 \u30e9\u30f3\u30c0\u30e0\u5316\u507d\u85ac\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\uff08RESTORE\uff09
\u30bb\u30c3\u30b7\u30e7\u30f3\uff1a\u00a0<\/b>\u30bb\u30c3\u30b7\u30e7\u30f3 PA048 (\u7db2\u819c\u3001\u785d\u5b50\u4f53\u539f\u8457\u8ad6\u6587)
\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b>10\u670820\u65e5\u65e5\u66dc\u65e5<\/span>\u756a\u76ee<\/sup>, 2024
\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b>\u5348\u5f8c2\u6642\uff5e\u5348\u5f8c3\u664215\u5206\uff08\u4e2d\u90e8\u590f\u6642\u9593\uff09<\/span>\u00a0\uff08\u5bfe\u9762\u3001\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\uff09
\u4f4d\u7f6e\uff1a\u00a0<\/b>\u30de\u30b3\u30fc\u30df\u30c3\u30af \u30d7\u30ec\u30a4\u30b9 \u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3 \u30bb\u30f3\u30bf\u30fc\u3001S405 \u53f7\u5ba4
\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/b>Allen Ho \u533b\u5b66\u535a\u58eb\u3001FACS\u3001FASRS\u3001Wills Eye Hospital \u306e\u7db2\u819c\u7814\u7a76\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u517c\u7db2\u819c\u30b5\u30fc\u30d3\u30b9\u5171\u540c\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3001Nanoscope Therapeutics, Inc. \u306e\u4e3b\u4efb\u533b\u7642\u9867\u554f\u3002<\/p>\n

\u30db\u30fc\u535a\u58eb\u306f\u8b1b\u6f14\u306e\u4e2d\u3067\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u306b\u3088\u308b\u91cd\u5ea6\u306e\u8996\u529b\u4f4e\u4e0b\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u8a66\u9a13\uff08RCT\uff09\u3067\u3042\u308bNanoscope\u793e\u306eRESTORE\u8a66\u9a13\u306e\u6700\u7d42\u7d50\u679c\u306b\u3064\u3044\u3066\u767a\u8868\u3057\u307e\u3059\u3002RESTORE\u8a66\u9a13\u306f\u3001\u3053\u306e\u60a3\u8005\u96c6\u56e3\u306b\u304a\u3044\u3066\u7d71\u8a08\u7684\u306b\u6709\u610f\u306a\u8996\u529b\u6539\u5584\u3092\u793a\u3057\u305f\u521d\u306eRCT\u3067\u3042\u308a\u3001Nanoscope\u793e\u306eRP\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u95a2\u3057\u3066\u4eca\u5f8c\u4e88\u5b9a\u3055\u308c\u3066\u3044\u308b\u751f\u7269\u88fd\u5264\u627f\u8a8d\u7533\u8acb\uff08BLA\uff09\u306e\u91cd\u8981\u306a\u90e8\u5206\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002.<\/p>\n

\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>Retina \u30b7\u30e7\u30fc\u30b1\u30fc\u30b9 (Eyecelerator @ AAO 2024)
\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b>10\u670817\u65e5\u6728\u66dc\u65e5<\/span>\u756a\u76ee<\/sup>, 2024
\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b>\u5348\u5f8c1\u664215\u5206\uff5e\u5348\u5f8c3\u664200\u5206\uff08\u4e2d\u90e8\u590f\u6642\u9593\uff09<\/span>
\u4f4d\u7f6e\uff1a\u00a0<\/b>\u30de\u30b3\u30fc\u30df\u30c3\u30af \u30d7\u30ec\u30a4\u30b9 \u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3 \u30bb\u30f3\u30bf\u30fc\u3001E450a \u5ba4
\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/b>\u30b5\u30df\u30e5\u30a8\u30eb\u30fb\u30d0\u30ed\u30fc\u30cd<\/span>\u533b\u5b66\u535a\u58eb\u3001\u6700\u9ad8\u533b\u7642\u8cac\u4efb\u8005<\/p>\n

\u30d0\u30ed\u30fc\u30cd\u535a\u58eb\u306f\u8b1b\u6f14\u306e\u4e2d\u3067\u3001\u9032\u884c\u6027\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u75c7\uff08AMD\uff09\u306b\u3088\u308b\u5730\u56f3\u72b6\u840e\u7e2e\uff08GA\uff09\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u6b21\u4e16\u4ee3\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002\u3053\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u6b21\u4e16\u4ee3MCO\u907a\u4f1d\u5b50\u6cbb\u7642\u85ac\u3067\u3042\u308bMCO-020\u3092\u4f7f\u7528\u3057\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u72ec\u81ea\u306e\u7a7a\u9593\u6a19\u7684\u578b\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u5149\u5b66\u7684\u907a\u4f1d\u5b50\u9001\u9054\u6cd5\u3092\u63a1\u7528\u3057\u3066\u3044\u307e\u3059\u3002\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306eGA\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u73fe\u5728\u3001GA\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7b2c1\/2\u76f8\u81e8\u5e8a\u8a66\u9a13\u306b\u5411\u3051\u305f\u6e96\u5099\u6bb5\u968e\u306b\u3042\u308a\u307e\u3059\u3002.<\/p>\n

\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>\u7db2\u819c\u6cbb\u7642\u306e\u672a\u6765 (Innovate Retina)
\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b>10\u670817\u65e5<\/span>\u756a\u76ee<\/sup>, 2024
\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b>\u5348\u5f8c6\u664224\u5206\uff08\u4e2d\u90e8\u590f\u6642\u9593\uff09<\/span>
\u4f4d\u7f6e\uff1a\u00a0<\/b>\u30a4\u30f3\u30bf\u30fc\u30b3\u30f3\u30c1\u30cd\u30f3\u30bf\u30eb \u30b7\u30ab\u30b4 \u30de\u30b0\u30cb\u30d5\u30a3\u30bb\u30f3\u30c8 \u30de\u30a4\u30eb\u3001\u30b0\u30e9\u30f3\u30c9 \u30dc\u30fc\u30eb\u30eb\u30fc\u30e0
\u30d1\u30cd\u30ea\u30b9\u30c8\uff1a\u00a0<\/b>\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3<\/span>\u3001PhD\u3001\u793e\u9577\u517c\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005<\/p>\n

\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u3001\u7db2\u819c\u75be\u60a3\u306b\u5bfe\u51e6\u3059\u308b\u305f\u3081\u306b\u958b\u767a\u4e2d\u306e\u6700\u5148\u7aef\u306e\u6cbb\u7642\u6cd5\u306e\u72b6\u6cc1\u3092\u89e3\u8aac\u3059\u308b\u30d1\u30cd\u30eb\u306b\u53c2\u52a0\u3057\u307e\u3059\u3002<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066
<\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u3063\u3066\u5931\u660e\u3057\u305f\u6570\u767e\u4e07\u4eba\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u5149\u907a\u4f1d\u5b66\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306e\u4e3b\u8981\u8cc7\u7523\u3067\u3042\u308bMCO-010\u306f\u3001\u6700\u8fd1\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08NCT04945772<\/a>\u540c\u793e\u306f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3092\u5b8c\u4e86\u3057\u305f\uff08NCT05417126<\/a>\uff09\u305d\u3057\u3066\u6700\u8fd1\u00a0\u7b2c3\u30d5\u30a7\u30fc\u30ba\u3092\u958b\u59cb\u3059\u308b\u8a08\u753b\u3092\u767a\u8868\u3057\u305f<\/a>\u00a02025\u5e74\u7b2c1\u56db\u534a\u671f\u306b\u767b\u9332\u8a66\u9a13\u3092\u5b9f\u65bd\u3057\u307e\u3059\u3002MCO-010\u306f\u3001RP\u3068Stargardt\u306e\u4e21\u65b9\u3067FDA\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001\u5730\u56f3\u72b6\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054MCO-020\u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b>
\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
212-600-1902
PR@nanostherapeutics.com<\/a><\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"

DALLAS,\u00a0Oct. 15, 2024\u00a0\u2014 Nanoscope Therapeutics, Inc., a BLA filing-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced that Nanoscope will present at the\u00a0AAO 2024 Annual Meeting\u00a0taking place\u00a0October 18-21, 2024\u00a0in\u00a0Chicago, Illinois, and the associated\u00a0Eyecelerator @ AAO 2024\u00a0and\u00a0Innovate Retina\u00a0meetings both taking place on\u00a0October 17th, 2024. Details for the presentations are as follows: Title:\u00a0Efficacy and Safety of MCO-010 Optogenetic Therapy for Vision Restoration in Patients with Severe Vision Loss Due to RP: Two-Year TOPLINE Results from a Phase\u00a02b\/3 Randomized, Sham-Controlled Clinical Trial (RESTORE)Session:\u00a0Session PA048 (Retina, Vitreous Original Papers)Session Date:\u00a0Sunday, October 20th, 2024Session Time:\u00a02:00PM \u2013 3:15 PM CDT\u00a0(In Person, On Demand)Location:\u00a0McCormick Place Convention Center, Room S405Presenter:\u00a0Allen Ho,\u00a0MD, FACS, FASRS, Director of […]<\/p>\n","protected":false},"author":6,"featured_media":5839,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5837","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Announces Presentations at the American Academy of Ophthalmology Annual Meeting 2024 - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Announces Presentations at the American Academy of Ophthalmology Annual Meeting 2024 - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-15T09:10:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T13:34:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_STARGARDTV3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_STARGARDTV3.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Announces Presentations at the American Academy of Ophthalmology Annual Meeting 2024\",\"datePublished\":\"2024-10-15T09:10:10+00:00\",\"dateModified\":\"2025-06-27T13:34:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/\"},\"wordCount\":486,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/NSCOPE_AAOLI_2024._.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/\",\"name\":\"Nanoscope Announces Presentations at the American Academy of Ophthalmology Annual Meeting 2024 - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/NSCOPE_AAOLI_2024._.jpg\",\"datePublished\":\"2024-10-15T09:10:10+00:00\",\"dateModified\":\"2025-06-27T13:34:47+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/NSCOPE_AAOLI_2024._.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/NSCOPE_AAOLI_2024._.jpg\",\"width\":2000,\"height\":2000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/10\\\/15\\\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Announces Presentations at the American Academy of Ophthalmology Annual Meeting 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u30012024\u5e74\u7c73\u56fd\u773c\u79d1\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a\u3067\u306e\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Announces Presentations at the American Academy of Ophthalmology Annual Meeting 2024 - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-10-15T09:10:10+00:00","article_modified_time":"2025-06-27T13:34:47+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_STARGARDTV3.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_STARGARDTV3.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Announces Presentations at the American Academy of Ophthalmology Annual Meeting 2024","datePublished":"2024-10-15T09:10:10+00:00","dateModified":"2025-06-27T13:34:47+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/"},"wordCount":486,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/10\/NSCOPE_AAOLI_2024._.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/","url":"https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u30012024\u5e74\u7c73\u56fd\u773c\u79d1\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a\u3067\u306e\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/10\/NSCOPE_AAOLI_2024._.jpg","datePublished":"2024-10-15T09:10:10+00:00","dateModified":"2025-06-27T13:34:47+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/10\/NSCOPE_AAOLI_2024._.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/10\/NSCOPE_AAOLI_2024._.jpg","width":2000,"height":2000},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/10\/15\/nanoscope-announces-presentations-at-the-american-academy-of-ophthalmology-annual-meeting-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Announces Presentations at the American Academy of Ophthalmology Annual Meeting 2024"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5837"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5837\/revisions"}],"predecessor-version":[{"id":9014,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5837\/revisions\/9014"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5839"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}